| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |